303 related articles for article (PubMed ID: 17696791)
1. Giardiasis: a pharmacotherapy review.
Escobedo AA; Cimerman S
Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
[TBL] [Abstract][Full Text] [Related]
2. Giardiasis: report of a case refractory to treatment.
Iza JA; Iza SN; Olivera MJ
Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
[TBL] [Abstract][Full Text] [Related]
3. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Carter ER; Nabarro LE; Hedley L; Chiodini PL
Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
Nabarro LE; Lever RA; Armstrong M; Chiodini PL
Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
[TBL] [Abstract][Full Text] [Related]
5. Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment.
Vivancos V; González-Alvarez I; Bermejo M; Gonzalez-Alvarez M
Curr Top Med Chem; 2018; 18(15):1287-1303. PubMed ID: 30277155
[TBL] [Abstract][Full Text] [Related]
6. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
Bourque DL; Neumayr A; Libman M; Chen LH
J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
[TBL] [Abstract][Full Text] [Related]
7. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
Lalle M
Infect Disord Drug Targets; 2010 Aug; 10(4):283-94. PubMed ID: 20429863
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.
Valdez CA; Tripp JC; Miyamoto Y; Kalisiak J; Hruz P; Andersen YS; Brown SE; Kangas K; Arzu LV; Davids BJ; Gillin FD; Upcroft JA; Upcroft P; Fokin VV; Smith DK; Sharpless KB; Eckmann L
J Med Chem; 2009 Jul; 52(13):4038-53. PubMed ID: 19480409
[TBL] [Abstract][Full Text] [Related]
9. Review article: the management of Giardiasis.
Vesy CJ; Peterson WL
Aliment Pharmacol Ther; 1999 Jul; 13(7):843-50. PubMed ID: 10383516
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antigiardial drugs.
Wright JM; Dunn LA; Upcroft P; Upcroft JA
Expert Opin Drug Saf; 2003 Nov; 2(6):529-41. PubMed ID: 14585063
[TBL] [Abstract][Full Text] [Related]
11. Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
Escrig JI; Miyamoto Y; Aznar AD; Eckmann L; Debnath A
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0073123. PubMed ID: 38063401
[TBL] [Abstract][Full Text] [Related]
12. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
[TBL] [Abstract][Full Text] [Related]
13. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with refractory giardiasis.
Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
[TBL] [Abstract][Full Text] [Related]
15. Refractory giardiasis: a molecular appraisal from a tertiary care centre in India.
Yadav P; Tak V; Mirdha BR; Makharia GK
Indian J Med Microbiol; 2014; 32(4):378-82. PubMed ID: 25297020
[TBL] [Abstract][Full Text] [Related]
16. Antigiardial drugs.
Harris JC; Plummer S; Lloyd D
Appl Microbiol Biotechnol; 2001 Dec; 57(5-6):614-9. PubMed ID: 11778868
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
Abboud P; Lemée V; Gargala G; Brasseur P; Ballet JJ; Borsa-Lebas F; Caron F; Favennec L
Clin Infect Dis; 2001 Jun; 32(12):1792-4. PubMed ID: 11360222
[TBL] [Abstract][Full Text] [Related]
18. Effect of Piper betle on Giardia intestinalis infection in vivo.
Pecková R; Doležal K; Sak B; Květoňová D; Kváč M; Nurcahyo W; Foitová I
Exp Parasitol; 2018 Jan; 184():39-45. PubMed ID: 29154846
[TBL] [Abstract][Full Text] [Related]
19. Refractory giardiasis in Spanish travellers.
Muñoz Gutiérrez J; Aldasoro E; Requena A; Comin AM; Pinazo MJ; Bardají A; Oliveira I; Valls ME; Gascon J
Travel Med Infect Dis; 2013; 11(2):126-9. PubMed ID: 23218784
[TBL] [Abstract][Full Text] [Related]
20. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.
Yereli K; Balcioğlu IC; Ertan P; Limoncu E; Onağ A
Clin Microbiol Infect; 2004 Jun; 10(6):527-9. PubMed ID: 15191380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
